fashion -WSS

fashion

author：fashion 2025-09-27 19:29:04 - browse：13395

Travere Therapeutics said Thursday that a study meant to confirm the benefit of its newly approved drug for a rare kidney disorder narrowly failed.

In the trial, 404 patients with the disorder, IgA nephropathy, were randomized to receive either Travere’s daily pill, Filspari, or irbesartan, a decades-old blood pressure drug often used to help manage the disease. Early data had showed the drug cut protein levels in the urine, a biomarker of kidney function, by half after nine months. That convinced regulators to give Filspari accelerated approval in February, pending full results using a more direct measure of kidney function.

The new data, after 24 months, showed that patients who received Filspari declined less quickly than those in the control group. But the results just missed statistical significance, with a P value of 0.058.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： YouTube cracks down on misinformation on cancer treatment

focus

WSS

Megan Rapinoe shares emotional post following US Women's World Cup exit

Heart disease in astronauts blamed on cosmic radiation

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

It costs an awful lot of money to give away a kidney

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

'Null' research findings aren't empty of meaning. Let's publish them

hotspot

fashion

entertainment

Guidelines to prevent youth baseball injuries need more muscle

What to know about the judge who will handle the Trump case

Bright Health sells Medicare Advantage business to Molina

Alnylam reports growth in sales of rare disease treatments

Malaria cases in Florida and Texas: Here’s what you need to know

What to know about the judge who will handle the Trump case

Hepatitis C has a cure — but many Americans still lack access to it

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Bright Health sells Medicare Advantage business to Molina

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

focus

The a glaring gap in research on serious mental illness and primary care

Be careful with at

Bird flu researchers hone in on Finland’s mink farms

Be careful with at

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Pharma showers House GOP doctor with campaign cash

knowledge

focus

hotspot

focus